PlainRecalls
FDA Drug Moderate Class II Terminated

Sumatriptan Succinate Tablets, 50 mg, packaged in a) 9 (1x9) Unit-of use blister card (NDC 62756-521-69) and b) 100 count bottles, (NDC 62756-521-88), Rx only, Sun Pharma, Cranbury, NJ

Reported: January 22, 2020 Initiated: December 26, 2019 #D-0659-2020

Product Description

Sumatriptan Succinate Tablets, 50 mg, packaged in a) 9 (1x9) Unit-of use blister card (NDC 62756-521-69) and b) 100 count bottles, (NDC 62756-521-88), Rx only, Sun Pharma, Cranbury, NJ

Reason for Recall

Failed Impurities/Degradation Specifications; out-of-specification results obtained for related substance.

Details

Units Affected
384/100 count bottles
Distribution
Product was distributed throughout the United States to 96 distributors and 1 repacker/relabeler.
Location
Cranbury, NJ

Frequently Asked Questions

What product was recalled?
Sumatriptan Succinate Tablets, 50 mg, packaged in a) 9 (1x9) Unit-of use blister card (NDC 62756-521-69) and b) 100 count bottles, (NDC 62756-521-88), Rx only, Sun Pharma, Cranbury, NJ. Recalled by Sun Pharmaceutical Industries, Inc.. Units affected: 384/100 count bottles.
Why was this product recalled?
Failed Impurities/Degradation Specifications; out-of-specification results obtained for related substance.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 22, 2020. Severity: Moderate. Recall number: D-0659-2020.